Clinical trial · Observational
Subtle Myocardial Deformation Abnormalities in Asymptomatic Nf-1 Patients
Prevalence of Subtle Myocardial Deformation Abnormalities in Asymptomatic Nf-1 Patients: is Cardiac Screening Needed?
NCT02505412CI-TRIAL-00018600unknownClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Subtle myocardial deformation abnormalities in asymptomatic nf-1 patients: is cardiac screening needed?
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Neurofibromatosis Type 1 | — | UNRESOLVED | — |
Interventions
Interventions (0)
Data not yet available
No intervention recorded.
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (1)
- measure
- myocardial deformation indices as measured in percentage (change of original length)
- timeFrame
- up to 2 years
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 1 Day
- Maximum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * asymptomatic NF1 patients * aged 0-17y and 11 months Exclusion Criteria: * clinical heart failure, * history of cardiovascular disease * chronic renal insufficiency
References
Publications (0)
Data not yet available
No reference posted for this study.